Paul F. Truex - May 31, 2022 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role
Director
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
MIST
Transactions as of
May 31, 2022
Transactions value $
$143,795
Form type
4
Date filed
6/1/2022, 09:32 PM
Previous filing
Jul 29, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIST Common Shares Options Exercise $8.98K +8.02K $1.12 8.02K May 31, 2022 Direct
transaction MIST Common Shares Options Exercise $69.4K +45.1K +562.28% $1.54 53.1K May 31, 2022 Direct
transaction MIST Common Shares Options Exercise $35.2K +22.9K +43.08% $1.54 76K May 31, 2022 Direct
transaction MIST Common Shares Options Exercise $2.19K +822 +1.08% $2.66 76.8K May 31, 2022 Direct
transaction MIST Common Shares Purchase $28K +5K +6.51% $5.60 81.8K May 31, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIST Stock Option (right to buy) Options Exercise $0 -8.02K -100% $0.00* 0 May 31, 2022 Common Shares 8.02K $1.12 Direct F1
transaction MIST Stock Option (right to buy) Options Exercise $0 -45.1K -100% $0.00* 0 May 31, 2022 Common Shares 45.1K $1.54 Direct F1
transaction MIST Stock Option (right to buy) Options Exercise $0 -22.9K -89.58% $0.00 2.66K May 31, 2022 Common Shares 22.9K $1.54 Direct F2
transaction MIST Stock Option (right to buy) Options Exercise $0 -822 -87.54% $0.00 117 May 31, 2022 Common Shares 822 $2.66 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.
F2 Twenty-five percent (25%) of the shares subject to the option shall vest on October 15, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
F3 Twenty-five percent (25%) of the shares subject to the option shall vest on November 21, 2019, and one thirty-sixth (1/36th) of the remaining shares subject to the option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.